Proteomic exploitation on prothymosin alpha-induced mononuclear cell activation

Area of Science:

• Immunology
• Proteomics
• Cell Biology

Background:

• Prothymosin alpha (ProTalpha) is implicated in cell proliferation and immune regulation.
• Limited data exists on ProTalpha-triggered signaling pathways.
• Understanding these pathways is crucial for its immunomodulatory functions.

Purpose of the Study:

• To investigate protein expression changes in ProTalpha-stimulated peripheral blood mononuclear cells (PBMC).
• To elucidate the signaling pathways activated by ProTalpha.
• To model ProTalpha's immunological mode of action over time.

Main Methods:

• Two-dimensional gel electrophoresis (2-DE) proteomic technology was employed.
• Peripheral blood mononuclear cells (PBMC) from healthy donors and cancer patients were stimulated with ProTalpha for 3 days.
• Mass spectrometry (PMF) was used to identify differentially expressed proteins.

Main Results:

• 53 differing protein spots were identified across 12 gels.
• Overexpression of key proteins including interleukin-1 receptor-associated kinase 4, heat-shock protein 90, and lipocalin 2 was observed.
• Upregulated proteins suggest roles in monocyte activation, T-cell proliferation, and cytotoxic effector functions.

Conclusions:

• ProTalpha triggers monocyte activation and enhances antigen presentation, stabilizing the monocyte-T-cell immune synapse.
• ProTalpha promotes T-cell proliferation and interleukin (IL)-2 production.
• ProTalpha-activated PBMC exhibit increased adhesion and cytotoxic lytic activity through the expression of specific effector proteins.